Skip to content

H2020FP7HORIZON

Institut de Recherches Servier

Country
FRFrance
Defence projects
0
Projects, all programmes
21
As coordinator
1
EU contribution (CORDIS)
EUR 477,694
Active
2008 to 2025

Projects

21 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EFFECTA European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across TissuesHORIZON2025ParticipantEUR 282,694
ChimSepChemistry improvement thanks to Separation by membrane processesHORIZON2023Associated partnerEUR 0
EUbOPENEUbOPEN: Enabling and Unlocking biology in the OPENH20202020ParticipantEUR 0
ZENITHZEbrafish Neuroscience Interdisciplinary Training HubH20202019PartnerEUR 0
MELLODDYMachinE Learning Ledger Orchestration for Drug DiscoverYH20202019ParticipantEUR 0
EBiSC2EBiSC2 – A sustainable European Bank for induced pluripotent Stem CellsH20202019ParticipantEUR 0
imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapiesH20202019ParticipantEUR 0
ESCulabEuropean Screening Centre; Unique Library for Attractive BiologyH20202018ParticipantEUR 0
EQIPDEuropean Quality In Preclinical DataH20202017ParticipantEUR 0
ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064H20202017ParticipantEUR 0
IMPRiNDInhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060H20202017ParticipantEUR 0
IC-3i-PhDInstitut Curie 3-i PhD ProgramH20202016PartnerEUR 0
RHAPSODYAssessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881H20202016ParticipantEUR 0
FRAGNETFRAGments training NETworkH20202016PartnerEUR 0
CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in bloodFP72015ParticipantNot stated
EU-AIMSEuropean Autism Interventions - A Multicentre Study for Developing New MedicationsFP72012ParticipantNot stated
PREDECTNew Models for Preclinical Evaluation of Drug Efficacy in Common Solid TumoursFP72011CoordinatorNot stated
IMIDIAImproving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetesFP72010ParticipantNot stated
PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical developmentFP72010ParticipantNot stated
NEWMEDSNovel Methods leading to New Medications in Depression and SchizophreniaFP72009ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.